U.S. drugmaker Pfizer raised its offer for AstraZeneca to $106 billion on Friday, but the British company promptly rejected the proposal, which would create the world’s biggest pharmaceuticals company.
U.S. drugmaker Pfizer raised its offer for AstraZeneca to $106 billion on Friday, but the British company promptly rejected the proposal, which would create the world’s biggest pharmaceuticals company.